AI Verdict
NUTX has stronger fundamentals based on our AI analysis.
NUVB vs NUTX Fundamental Comparison
| Metric | NUVB | NUTX |
|---|---|---|
| Revenue | $62.9M | $875.3M |
| Net Income | $-204.6M | $70.8M |
| Net Margin | -325.3% | 8.1% |
| ROE | -66.9% | 21.5% |
| ROA | -34.4% | 7.7% |
| Current Ratio | 6.95x | 3.41x |
| Debt/Equity | 0.15x | 0.09x |
| EPS | $-0.60 | $10.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NUVB vs NUTX: Frequently Asked Questions
Is NUVB or NUTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NUTX has stronger fundamentals. NUVB is rated STRONG SELL (92% confidence) while NUTX is rated STRONG BUY (85% confidence). This is not investment advice.
How does NUVB compare to NUTX fundamentally?
Nuvation Bio Inc. has ROE of -66.9% vs Nutex Health Inc.'s 21.5%. Net margins are -325.3% vs 8.1% respectively.
Which stock pays higher dividends, NUVB or NUTX?
NUVB has a dividend yield of N/A or no dividend while NUTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NUVB or NUTX for long term?
For long-term investing, consider that NUVB has STRONG SELL rating with 92% confidence, while NUTX has STRONG BUY rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NUVB vs NUTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NUVB vs NUTX, the AI consensus favors NUTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.